Results 261 to 270 of about 1,735,150 (286)
Some of the next articles are maybe not open access.
AIDS Patient Care and STDs, 2001
In this observational single-center cohort study outside the clinical trial setting, outcome and predictors of virologic failure of highly active antiretroviral therapy (HAART) containing a protease inhibitor were evaluated in human immunodeficiency (HIV)-infected persons.
H, Knobel +8 more
openaire +2 more sources
In this observational single-center cohort study outside the clinical trial setting, outcome and predictors of virologic failure of highly active antiretroviral therapy (HAART) containing a protease inhibitor were evaluated in human immunodeficiency (HIV)-infected persons.
H, Knobel +8 more
openaire +2 more sources
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences
Journal of Antimicrobial Chemotherapy, 2015The objective of this study was to evaluate the incidence, prevalence and clinical consequences of virological failure (VF) to raltegravir-based regimens in Spain.A multicentre, retrospective, observational study was performed in 10 tertiary hospitals (January 2006 to June 2013).
Santos, José R. +13 more
openaire +5 more sources
PROTEASE INHIBITOR RESISTANCE IN SOUTH AFRICAN CHILDREN WITH VIROLOGIC FAILURE
Pediatric Infectious Disease Journal, 2009In South Africa, first-line antiretroviral therapy for children younger than 3 years of age combines a protease inhibitor (PI) with 2 nucleoside reverse transcription inhibitors. In our study, some pediatric patients received ritonavir (RTV) as single PI (RTV-sPI) and others ritonavir-boosted lopinavir (LPV/r), which has a higher resistance barrier. We
Van Zyl G.U. +6 more
openaire +3 more sources
Tackling virological failure in HIV-infected children living in Africa
Expert Review of Anti-infective Therapy, 2015Drug resistance in HIV-infected children is one of the main contributors to antiretroviral treatment (ART) failure, especially in developing countries. Sub-Saharan Africa has the largest burden of pediatric HIV infection in the world. Herein, we systematically review the current status of ART failure in HIV-infected African children.
Mohammad-Ali, Jenabian +5 more
openaire +2 more sources
Virological failure and subsequent resistance profiles in individuals exposed to atazanavir
AIDS, 2007Few data exist regarding the resistance profile in individuals receiving atazanavir. We found that ritonavir-boosted atazanavir is not associated with the development of primary genotypic resistance in individuals failing this combination, without previous protease inhibitor failure.
Justin, Stebbing +8 more
openaire +2 more sources
Continue Antiretroviral Therapy during Virologic Failure?
Clinical Infectious Diseases, 2002Davey Smith, Joseph Wong
openaire +1 more source